SMARCA4 and neoplasm: A statistically significant decrease in Ki67 immunoreactivity was observed in the WT Brg1-positive tumor cells that did not express pRb1T821/826 compared with WT Brg1- positive tumor cells that did express pRb1T821/826 (positive) (26% and 72.0%, respectively; p=2.0E-11).